Trending...
- OneVizion Announces Next Phase of Growth as Brad Kitchens Joins Board of Directors
- Tacoma City Council Announces City Manager Finalists
- "They Said It Was Impossible": This Bottle Turns Any Freshwater Source Into Ice-Cold, Purified Drinking Water in Seconds
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced that two peer-reviewed publications using the GeoMx® Digital Spatial Profiler have been published in Nature and Nature Communications. These papers describe the use of Digital Spatial Profiling (DSP) technology to investigate SARS-CoV-2 infection and drive diagnostic, prevention, and treatment strategies.
The GeoMx DSP was used to profile lung tissue collected on autopsy from patients who had succumbed to COVID-19 infection. Researchers used the Cancer Transcriptome Atlas (CTA) plus a spike-in panel to detect additional lung genes and SARS-CoV-2 virus. In total, over 1,800 genes were interrogated as part of the study. This information enabled the researchers to connect bulk RNA sequencing data to the lung tissue's spatial architecture by looking at the distribution and transcriptional activity of cells, providing an important basis for understanding COVID-19 and lung pathology.
The first study, published in Nature Communications and led by Dr. Christopher Mason at Weill Cornell Medicine, was entitled "Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveal unique host responses, viral diversification, and drug interactions." In this study, the GeoMx platform was used to molecularly characterize alveolar lung tissue. The team found spatially-restricted expression of the gene ACE2—which is a SARS-CoV-2 cellular target—and SARS-CoV-2 virus in some of the same regions. From the spatially-resolved expression profiles, they were able to infer the abundance of different immune and non-immune cells and found unique cellular distributions in COVID-19 patients compared to normal control lung samples.
"We were interested in characterizing the diversity of SARS-CoV-2 circulating in the population as well as the diversity of response to infection within a single patient. By using cell-type deconvolution, we were able to measure relative levels of 16 different cell populations from COVID-19 cases and controls using a single slide from each patient," said Dr. Mason, who serves on NanoString's Scientific Advisory Board and is a paid consultant for the company. "This deep molecular profiling helped us create a more complete picture of how the virus circulates in the body and how it elicits a variable response in infected individuals."
More on Washingtoner
The second study, "The spatial landscape of lung pathology during COVID-19 progression", was published in Nature and was led by Dr. Robert Schwartz, Dr. Alain Borczuk, and Dr. Olivier Elemento at Weill Cornell Medicine. The team found a difference in immune composition between individuals with early (<14 days) versus late (>30 days) mortality after admission to a hospital with COVID-19 symptoms. In "early" patients, immune cells known as neutrophils were seen at rates comparable to other acute respiratory distress syndromes (ARDS). However, with time it appears that a different pattern emerges; namely, increased abundance of macrophages, more inflammation, and wound healing (fibrosis) in patients with late mortality.
"Spatial profiling of the samples allowed us to separately characterize the transcriptional response in the airway, alveolar, and vascular compartments of the lung, and enabled us to see that the early period of severe COVID-19 disease is comprised of inflammatory responses to SARS-CoV-2," said Dr. Schwartz. "We also discovered late COVID-19 might be driven by pathogen-independent mechanisms of an immune response with aberrant resolution."
"These studies demonstrate the value of the GeoMx Digital Spatial Profiler in characterizing the tissue damage induced by SARS-CoV-2 infection," said Sarah Warren, Ph.D., Senior Director of Translational Science at NanoString. "By applying high-plex molecular profiling on the formalin fixed, paraffin embedded (FFPE) tissues that are safe to work with from COVID-19 autopsies, we can understand how the virus is inducing and altering immune response and tissue repair in the patients' lungs."
The GeoMx Digital Spatial Profiler enables researchers to rapidly and quantitatively characterize tissue morphology with a high-throughput, high-plex RNA and protein profiling system that preserves precious samples for future analyses. NanoString and its collaborators have presented DSP data in dozens of abstracts at major scientific meetings, and in more than 40 peer reviewed publications, demonstrating DSP's utility to address a wide range of biological questions in FFPE and frozen tissues. Interested parties can learn more about DSP by visiting https://www.nanostring.com/scientific-content/technology-overview/digital-spatial-profiling-technology.
More on Washingtoner
NanoString launched its Technology Access Program (TAP) for the recently announced single and subcellular Spatial Molecular Imager to complement the existing TAP program for GeoMx. Under the program, customers can submit tissue samples to NanoString to be analyzed using both spatial profiling platforms and receive a complete data package. Researchers interested in participating in NanoString's Technology Access Program should contact the company at TAP@nanostring.com.
About NanoString Technologies, Inc.
NanoString Technologies is a leading provider of life science tools for discovery and translational research. The company's nCounter® Analysis System is used in life sciences research and has been cited in more than 4,000 peer-reviewed publications. The nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company's GeoMx® Digital Spatial Profiler enables highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections.
For more information, please visit www.nanostring.com.
NanoString, NanoString Technologies, the NanoString logo, GeoMx, and nCounter are trademarks or registered trademarks of NanoString Technologies, Inc. in various jurisdictions.
The GeoMx DSP was used to profile lung tissue collected on autopsy from patients who had succumbed to COVID-19 infection. Researchers used the Cancer Transcriptome Atlas (CTA) plus a spike-in panel to detect additional lung genes and SARS-CoV-2 virus. In total, over 1,800 genes were interrogated as part of the study. This information enabled the researchers to connect bulk RNA sequencing data to the lung tissue's spatial architecture by looking at the distribution and transcriptional activity of cells, providing an important basis for understanding COVID-19 and lung pathology.
The first study, published in Nature Communications and led by Dr. Christopher Mason at Weill Cornell Medicine, was entitled "Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveal unique host responses, viral diversification, and drug interactions." In this study, the GeoMx platform was used to molecularly characterize alveolar lung tissue. The team found spatially-restricted expression of the gene ACE2—which is a SARS-CoV-2 cellular target—and SARS-CoV-2 virus in some of the same regions. From the spatially-resolved expression profiles, they were able to infer the abundance of different immune and non-immune cells and found unique cellular distributions in COVID-19 patients compared to normal control lung samples.
"We were interested in characterizing the diversity of SARS-CoV-2 circulating in the population as well as the diversity of response to infection within a single patient. By using cell-type deconvolution, we were able to measure relative levels of 16 different cell populations from COVID-19 cases and controls using a single slide from each patient," said Dr. Mason, who serves on NanoString's Scientific Advisory Board and is a paid consultant for the company. "This deep molecular profiling helped us create a more complete picture of how the virus circulates in the body and how it elicits a variable response in infected individuals."
More on Washingtoner
- Amy Turner Receives 2025 ENPY Partnership Builder Award from The Community Foundation
- Hubble Tension Solved? Study finds evidence of an 'Invisible Bias' in How We Measure the Universe
- Boonuspart.ee Acquires Kasiino-boonus.ee to Strengthen Its Position in the Estonian iGaming Market
- Vines of Napa Launches Partnership Program to Bolster Local Tourism and Economic Growth
- Meet Laurent Gabay Global Apparel, Accessories, and Textiles Sourcing — His Firm Fashion Sourcing
The second study, "The spatial landscape of lung pathology during COVID-19 progression", was published in Nature and was led by Dr. Robert Schwartz, Dr. Alain Borczuk, and Dr. Olivier Elemento at Weill Cornell Medicine. The team found a difference in immune composition between individuals with early (<14 days) versus late (>30 days) mortality after admission to a hospital with COVID-19 symptoms. In "early" patients, immune cells known as neutrophils were seen at rates comparable to other acute respiratory distress syndromes (ARDS). However, with time it appears that a different pattern emerges; namely, increased abundance of macrophages, more inflammation, and wound healing (fibrosis) in patients with late mortality.
"Spatial profiling of the samples allowed us to separately characterize the transcriptional response in the airway, alveolar, and vascular compartments of the lung, and enabled us to see that the early period of severe COVID-19 disease is comprised of inflammatory responses to SARS-CoV-2," said Dr. Schwartz. "We also discovered late COVID-19 might be driven by pathogen-independent mechanisms of an immune response with aberrant resolution."
"These studies demonstrate the value of the GeoMx Digital Spatial Profiler in characterizing the tissue damage induced by SARS-CoV-2 infection," said Sarah Warren, Ph.D., Senior Director of Translational Science at NanoString. "By applying high-plex molecular profiling on the formalin fixed, paraffin embedded (FFPE) tissues that are safe to work with from COVID-19 autopsies, we can understand how the virus is inducing and altering immune response and tissue repair in the patients' lungs."
The GeoMx Digital Spatial Profiler enables researchers to rapidly and quantitatively characterize tissue morphology with a high-throughput, high-plex RNA and protein profiling system that preserves precious samples for future analyses. NanoString and its collaborators have presented DSP data in dozens of abstracts at major scientific meetings, and in more than 40 peer reviewed publications, demonstrating DSP's utility to address a wide range of biological questions in FFPE and frozen tissues. Interested parties can learn more about DSP by visiting https://www.nanostring.com/scientific-content/technology-overview/digital-spatial-profiling-technology.
More on Washingtoner
- Finland's €1.3 Billion Digital Gambling Market Faces Regulatory Tug-of-War as Player Protection Debate Intensifies
- Angels Of Dirt Premieres on Youtube, Announces Paige Keck Helmet Sponsorship for 2026 Season
- "They Said It Was Impossible": This Bottle Turns Any Freshwater Source Into Ice-Cold, Purified Drinking Water in Seconds
- Patron Saints Of Music Names Allie Moskovits Head Of Sync & Business Development
- Dave Aronberg Named 2026 John C. Randolph Award Recipient by Palm Beach Fellowship of Christians & Jews
NanoString launched its Technology Access Program (TAP) for the recently announced single and subcellular Spatial Molecular Imager to complement the existing TAP program for GeoMx. Under the program, customers can submit tissue samples to NanoString to be analyzed using both spatial profiling platforms and receive a complete data package. Researchers interested in participating in NanoString's Technology Access Program should contact the company at TAP@nanostring.com.
About NanoString Technologies, Inc.
NanoString Technologies is a leading provider of life science tools for discovery and translational research. The company's nCounter® Analysis System is used in life sciences research and has been cited in more than 4,000 peer-reviewed publications. The nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company's GeoMx® Digital Spatial Profiler enables highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections.
For more information, please visit www.nanostring.com.
NanoString, NanoString Technologies, the NanoString logo, GeoMx, and nCounter are trademarks or registered trademarks of NanoString Technologies, Inc. in various jurisdictions.
0 Comments
Latest on Washingtoner
- Senseeker Machining Company Acquires Axis Machine to Establish Machining Capability for Improved Supply Chain Control and Shorter Delivery Times
- VC Fast Pitch Is Coming to Maryland on March 26th
- Patent Bar Exam Candidates Achieve 30% Higher Pass Rates with Wysebridge's 2026 Platform
- Municipal Carbon Field Guide Launched by LandConnect -- New Revenue Streams for Cities Managing Vacant Land
- Hoy Law Wins Supreme Court Decision Establishing Federal Trucking Regulations as the Standard of Care in South Dakota
- Tacoma City Council Announces City Manager Finalists
- City of Tacoma Observes Presidents Day on February 16
- Dr. Rashad Richey's Indisputable Shatters Records, Over 1 Billion YouTube Views, Top 1% Podcast, 3.2 Million Viewers Daily
- Grand Opening: New Single-Family Homes Now Open for Sale at Heritage at Manalapan
- Spokane: Presidents Day is a Parking Meter Holiday
- Shelter Structures America Announces Distribution Partnership with The DuraTrac Group
- The OpenSSL Corporation Releases Its Annual Report 2025
- Iranian-Born Engineer Mohsen Bahmani Introduces Propeller-Less Propulsion for Urban Air Mobility
- Aleen Inc. (C S E: ALEN.U) Advances Digital Wellness Vision with Streamlined Platform Navigation and Long-Term Growth Strategy
- RimbaMindaAI Officially Launches Version 3.0 Following Strategic Breakthrough in Malaysian Market Analysis
- Fed Rate Pause & Dow 50k: Irfan Zuyrel on Liquidity Shifts, Crypto Volatility, and the ASEAN Opportunity
- 20/20 Institute Launches Updated Vision Correction Procedures Page for Denver & Colorado Springs
- OneVizion Announces Next Phase of Growth as Brad Kitchens Joins Board of Directors
- New Children's Picture Book "Diwa of Mount Luntian" Focuses on Calm, Culture, and Connection for Today's Families
- Actor, Spokesperson Rio Rocket Featured in "Switch to AT&T" Campaign Showing How Customers Can BYOD and Keep Their Number